Related Experiment Video

Updated: May 18, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Inherited thrombocytopenias: the evolving spectrum

C L Balduini1, A Pecci, P Noris

  • 1Department of Internal Medicine, University of Pavia – IRCCS Policlinico San Matteo Foundation, Pavia, Italy. c.balduini@smatteo.pv.it

Hamostaseologie
|September 14, 2012
PubMed

Insights

Inherited thrombocytopenias are increasingly understood, yet many cases lack diagnosis. New treatments, like oral thrombopoietin mimetics for MYH9-related diseases, offer hope.

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • The field of inherited thrombocytopenias has seen significant expansion with new gene discoveries.
  • A substantial portion of patients with inherited thrombocytopenias still lack a definitive diagnosis.
  • Existing diagnostic algorithms require updates to incorporate recently identified disorders.

Purpose of the Study:

  • To review the general aspects of inherited thrombocytopenias.
  • To provide a detailed description of MYH9-related diseases and ANKRD26-related thrombocytopenia.
  • To highlight emerging therapeutic perspectives in managing inherited thrombocytopenias.

Main Methods:

  • Literature review of inherited thrombocytopenias.
  • Focus on genetic mutations and their clinical manifestations.
  • Discussion of current and novel therapeutic strategies.

Main Results:

  • MYH9-related diseases encompass previously distinct conditions.
  • ANKRD26-related thrombocytopenia is identified as a frequent inherited form.
  • Oral thrombopoietin mimetics show efficacy in increasing platelet counts for MYH9-related thrombocytopenia.

Conclusions:

  • Advances in understanding inherited thrombocytopenias are ongoing.
  • MYH9-related and ANKRD26-related thrombocytopenias are common forms requiring attention.
  • Novel therapies like thrombopoietin mimetics represent a significant advancement in patient care.

More Related Videos

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Ferric Chloride-induced Murine Thrombosis Models10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...